Nanjing Vazyme Biotech Co., Ltd. (688105.SS)
CNY 23.21
(-1.9%)
CNY 23.21
(-1.9%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.74 Billion CNY | -4.31% |
| 2022 | 6 Billion CNY | 30.35% |
| 2021 | 4.6 Billion CNY | 185.87% |
| 2020 | 1.61 Billion CNY | 396.91% |
| 2019 | 324.33 Million CNY | 29.35% |
| 2018 | 250.74 Million CNY | 33.1% |
| 2017 | 188.39 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 4.89 Billion CNY | -1.65% |
| 2024 Q1 | 5.41 Billion CNY | -5.79% |
| 2024 Q2 | 4.97 Billion CNY | -8.01% |
| 2023 Q2 | 5.75 Billion CNY | -8.9% |
| 2023 FY | 5.74 Billion CNY | -4.31% |
| 2023 Q4 | 5.74 Billion CNY | 0.6% |
| 2023 Q3 | 5.71 Billion CNY | -0.76% |
| 2023 Q1 | 6.31 Billion CNY | 5.22% |
| 2022 Q2 | 5.46 Billion CNY | 0.18% |
| 2022 Q1 | 5.45 Billion CNY | 18.49% |
| 2022 FY | 6 Billion CNY | 30.35% |
| 2022 Q4 | 6 Billion CNY | 2.04% |
| 2022 Q3 | 5.88 Billion CNY | 7.61% |
| 2021 FY | 4.6 Billion CNY | 185.87% |
| 2021 Q2 | 2.13 Billion CNY | 3.45% |
| 2021 Q4 | 4.6 Billion CNY | 101.23% |
| 2021 Q3 | 2.28 Billion CNY | 7.23% |
| 2021 Q1 | 2.06 Billion CNY | 28.07% |
| 2020 FY | 1.61 Billion CNY | 396.91% |
| 2020 Q4 | 1.61 Billion CNY | 0.0% |
| 2020 Q2 | 1.25 Billion CNY | 0.0% |
| 2019 FY | 324.33 Million CNY | 29.35% |
| 2018 FY | 250.74 Million CNY | 33.1% |
| 2017 FY | 188.39 Million CNY | 0.0% |